News Quantified

TFFP – tff pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

TFF Pharmaceuticals Announces It Will Wind Down Operations

TFF Pharmaceuticals (TFFP) Upgraded to Strong Buy: Here's Why [Yahoo! Finance]

Form PRE 14A TFF Pharmaceuticals, For: Dec 11

Form 8-K TFF Pharmaceuticals, For: Dec 04

Form 10-Q TFF Pharmaceuticals, For: Sep 30

Form SC 13G/A TFF Pharmaceuticals, Filed by: Carlson Capital, L.P.

Form NT 10-Q TFF Pharmaceuticals, For: Sep 30

Top News Gainers

4/15 TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) for use of its Thin Film Freezing Technology Platform 8.8%

1/28 TFF Pharmaceuticals Reports Continued Progress Across Programs in Corporate Update 6.8%

4/29 Form 10-K/A TFF Pharmaceuticals, For: Dec 31 6.7%

3/19 TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation Powder to Treat Invasive Pulmonary Aspergillosis (IPA) 4.3%

4/30 TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on Repurposing Niclosamide for COVID-19 Treatment at AAPS Meeting 2.8%

3/26 Form 8-K TFF Pharmaceuticals, For: Mar 26 2.6%

4/25 TFF Pharmaceuticals (NASDAQ: TFFP) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $5.25 price target on the stock. 2.5%

4/17 Form 4 TFF Pharmaceuticals, For: Apr 15 Filed by: Fletcher Aaron G.L. 2.3%

4/8 TFF Pharmaceuticals (NASDAQ: TFFP) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.0%

11/19 TFF Pharmaceuticals Selects LaVoieHealthScience as Investor Relations and Corporate Communications Partner 1.8%

Top News Decliners

3/9 TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor for Partnering Efforts in China and South Korea -11.1%

3/23 TFF Pharmaceuticals Reschedules Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call for March 26, 2020 to 4:30 PM (EDT) -7.8%

4/6 Form 4 TFF Pharmaceuticals, For: Apr 02 Filed by: Fletcher Aaron G.L. -4.0%

12/17 Form 8-K TFF Pharmaceuticals, For: Dec 17 -2.7%

10/24 TFF Pharmaceuticals Prices $22 Million Public Offering of Common Stock -2.3%

4/17 TFF Pharmaceuticals to Present at April 2020 Virtual Investor Summit -2.0%

1/31 Form 8-K TFF Pharmaceuticals, For: Jan 27 -1.9%

4/1 TFF Pharmaceuticals (NASDAQ: TFFP) had its "buy" rating re-affirmed by analysts at Roth Capital. -1.3%

11/25 TFF Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Voriconazole Inhalation Powder, to Treat Invasive Pulmonary Aspergillosis (IPA) -1.2%

4/9 TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine -1.0%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day